Solutions
AiCure Platform Optimize Drug Development & Patient Care with AiCure
AiCure's Platform allows pharmaceutical and biotech companies to remotely collect and analyze objective, quantifiable physiological and behavioral data using digital biomarkers and predictive analytics.
Collect PHI through AiCure’s mobile application
Understand drug response and objectively quantify difficult-to-measure symptoms
Develop insights only available from direct visualization of patient experience
Tap into a larger data set to address questions of generalizability, diversity, and overall potential market impact
Leverage Predictive Analytics to identify risk and drive timely interventions
Support for integration of additional patient data sources, patient companion apps, and with clinical workflows and records
Key Platform Features

Long-term secure storage of protected health information (PHI) complies with HIPAA, GDPR, and 21CFR11 or for de-identified PHI

Access to templates and tools for model development, analytics and clinical annotation

Supplemental access to de-identified patient audio and video data for benchmarking

Support for integration of additional patient data sources, patient companion apps, and with clinical workflows and records
AiCure’s currently available biomarkers by disease area include:
Major Depressive Disorder - Facial expressivity, speech/acoustics, rate of head movement
PTSD - Facial expressivity, movement, speech prosody, natural language content
Essential Tremor - Hand motion
Parkinson’s Disease - Facial tremor, mood, harmonics-to-noise ratio, rate of speech
Tardive Dyskinesia - Movement of face, lips, jaw and tongue
Schizophrenia - Head movement
Collaboration with clients is ongoing to establish new biomarkers.
Predictive Analytics
Predictive Analytics for fast data aggregation and exploration to develop, tune and deploy machine learning models in a regulatory compliant manner.
Helps sponsors understand how likely a patient is to adhere to their treatment plan or to drop out over the course of an entire study with high accuracy
Enhance site selection with tools for data teams to tune, deploy and monitor performance
Enables patient-centric interventions that provide personalized encouragement, focusing efforts on the patients most in need